OncoSec Medical Inc (ONCSQ)

[Titan V]

I doubt we will see any interim data by year end as well given the 24 weeks treatment cycle. At the earliest, we may see something at ASCO-SITC in February, or AACR in April, or at the latest at ASCO in June 2018. The only major scientific conference in 2017 will be SITC in November when patients would not have even completed their treatment cycles.

One thing to look forward to in 2017 is that licensing milestone that is yet to be announced. I don't expect it to be something big, but perhaps another trial supported in drug supply by another big pharma.